Clinical Trial Update: Phase 2, Single-arm Trial of BMS-986340 in Association With Nivolumab, Trifluridine/Tipiracil and Bevacizumab for Patients Refractory to Standard of Care Treatment and With Microsatellite-stable Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 single-arm trial of BMS-986340 in combination with nivolumab, trifluridine/tipiracil, and bevacizumab for microsatellite-stable colorectal cancer has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• BMS-986340
• Bevacizumab (bevacizumab)
• Lonsurf (trifluridine/tipiracil)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Microsatellite-stable Colorectal Cancer, Standard of Care | Phase 2 | Status: SUSPENDED